SHANGHAI BIRDIE BIOTECH INC has a total of 43 patent applications. Its first patent ever was published in 2013. It filed its patents most often in Argentina, Canada and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are OSTEOARTHRITIS SCIENCES INC, ALFACYTE LTD and DEFENSIN THERAPEUTICS APS.
# | Country | Total Patents | |
---|---|---|---|
#1 | Argentina | 6 | |
#2 | Canada | 6 | |
#3 | WIPO (World Intellectual Property Organization) | 6 | |
#4 | China | 4 | |
#5 | Israel | 4 | |
#6 | Republic of Korea | 3 | |
#7 | Taiwan | 3 | |
#8 | Australia | 2 | |
#9 | United States | 2 | |
#10 | Brazil | 1 | |
#11 | EPO (European Patent Office) | 1 | |
#12 | India | 1 | |
#13 | Japan | 1 | |
#14 | Mexico | 1 | |
#15 | Singapore | 1 | |
#16 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Li Lixin | 32 |
#2 | Lixin Li | 11 |
Publication | Filing date | Title |
---|---|---|
CN106535938A | Combination therapy compositions and methods for treating cancers | |
AU2013292894A1 | Compounds for targeted immunotherapy |